TONYA GOLLAHALLI: Open Payments
NPI 1588102305 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 57 payments from 16 companies in 2025. Trend: 2023 $412 · 2024 $1,890 · 2025 $1,666
Food & beverage: $1,666
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 15 | $519 |
| Radius Health, Inc. | 7 | $219 |
| BETA BIONICS, INC. | 3 | $169 |
| Novo Nordisk Inc | 7 | $161 |
| Mannkind Corporation | 4 | $95 |
| ABBVIE INC. | 5 | $94 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $73 |
| Ascensia Diabetes Care Us Inc. | 2 | $57 |
| Dexcom, Inc. | 1 | $50 |
| Abbott Laboratories | 2 | $47 |
Products named: Korlym, Tymlos, iLet Bionic Pancreas, AFREZZA, Wegovy, Dexcom G6 Transmitter, ISTURISA, Ozempic.
Industry payments across IL — which companies pay providers there.
